Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
Open Access
- 30 March 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 61 (1) , 309-318
Abstract
SSc-associated pulmonary arterial hypertension (SSc-APAH) is a late but devastating complication of SSc. Early identification of SSc-APAH may improve survival. We examined the role of circulating miRNAs in SSc-APAH. Using quantitative RT-PCR the abundance of mature miRNAs in plasma was determined in 85 female patients with ACA-positive lcSSc. Twenty-two of the patients had SSc-APAH. Sixty-three SSc controls without PAH were matched for disease duration. Forty-six selected miRNA plasma levels were correlated with clinical data. Longitudinal samples were analysed from 14 SSc-APAH and 27 SSc patients. The disease duration was 12 years for the SSc-APAH patients and 12.7 years for the SSc controls. Plasma expression levels of 11 miRNAs were lower in patients with SSc-APAH. Four miRNAs displayed higher plasma levels in SSc-APAH patients compared with SSc controls. There was significant difference between groups for miR-20a-5p and miR-203a-3p when correcting for multiple comparisons (P = 0.002 for both). Receiver operating characteristics curve showed AUC = 0.69–0.83 for miR-21-5p and miR-20a-5p or their combination. miR-20a-5p and miR-203a-3p correlated inversely with NT-pro-Brain Natriuretic Protein levels (r = −0.42 and −0.47). Mixed effect model analysis could not identify any miRNAs as predictor of PAH development. However, miR-20a-5p plasma levels were lower in the longitudinal samples of SSc-APAH patients than in the SSc controls. Our study links expression levels of the circulating plasma miRNAs, especially miR-20a-5p and miR-203a-3p, to the occurrence of SSc-APAH in female patients with ACA-positive lcSSc.Keywords
Funding Information
- Danish Rheumatism Association (R99-A1937, R97-A1028)
- Greta and Johan Kock Foundation
- Alfred Österlund Foundation
- King Gustaf V’s 80th Birthday Fund
- Swedish Rheumatism Association
This publication has 46 references indexed in Scilit:
- MicroRNAs in pulmonary arterial remodelingCellular and Molecular Life Sciences, 2013
- Circulating MicroRNA Expression Profiles Associated With Systemic Lupus ErythematosusArthritis & Rheumatism, 2013
- MicroRNA-21 Integrates Pathogenic Signaling to Control Pulmonary HypertensionCirculation, 2012
- Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficultScandinavian Journal of Rheumatology, 2010
- Telangiectases in Scleroderma: A Potential Clinical Marker of Pulmonary Arterial HypertensionThe Journal of Rheumatology, 2009
- Repression of the miR‐17‐92 cluster by p53 has an important function in hypoxia‐induced apoptosisThe EMBO Journal, 2009
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- MicroRNAs, the immune system and rheumatic diseaseNature Clinical Practice Rheumatology, 2008
- Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung diseaseArthritis Research & Therapy, 2007
- Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001Rheumatology, 2005